# TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE)

NDC: 51662-1430
Generic name: TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE)
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAMUSCULAR
Marketing started: 20200110

FDA application: NDA017530

## Active ingredients

- TRIMETHOBENZAMIDE HYDROCHLORIDE: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1430"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1430
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9bd0bfa0-c189-751c-e053-2a95a90a5f5a